GlaxoSmithKline / Flickr.com
GSK announced today that it will invest £275 million ($360 million) in expanding its UK manufacturing capabilities, despite Brexit.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
GSK, Brexit, investment, EU Referendum, Patent Box